- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.09. | Boehringer Ingelheim offloads Shanghai CDMO to local antibody developer | ||
| 24.09. | GSK slammed for 'grossly misleading' and 'totally unacceptable' behavior | ||
| 24.09. | Elevar wins FDA nod for bile duct cancer drug Lyrfigtu, a first for a Korean firm | ||
| 24.09. | Otsuka JV recalls one lot of sodium chloride over labeling issue | ||
| 24.09. | Glaukos courts NBA champion Stephen Curry for new keratoconus awareness campaign | ||
| 24.09. | Biogen springs social media kidney health campaign with Olympic gymnast Suni Lee | ||
| 23.09. | Novo CEO sees advantages in souping up NYSE listing: report | ||
| 23.09. | Eli Lilly CEO touts 70% share as Medicare GLP-1 program reaches 700K seniors | ||
| 23.09. | Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks | ||
| 23.09. | AstraZeneca recommits to youth health to dial funding past $100M | ||
| 22.09. | Bristol Myers cuts another 265 jobs tied to New Jersey headquarters | ||
| 22.09. | Par Health recalls IV sedative in US, flagging presence of cellulose, stopper material | ||
| 22.09. | 'Europe does not value what you do': 9 pharmas make urgent call for bloc to beef up innovation muscle | ||
| 22.09. | Travere CEO Eric Dube to step down after transforming the rare disease biotech | ||
| 22.09. | Organon-commissioned survey finds 1 in 3 UK women feel their migraine pain not taken seriously | ||
| 21.09. | Trump calls for some childhood vaccines be split into smaller doses | ||
| 21.09. | J&J firms up Caplyta's 1st phase 3 win in bipolar-associated manic episodes | ||
| 21.09. | IntraBio's Aqneursa scores expansion, now the first treatment for rare ataxia | ||
| 21.09. | Novo struggles to appease restive investors with consumer plans, blockbuster ambitions | ||
| 21.09. | New MFN deal details reignite concerns that Trump's pricing policy favors pharma | ||
| 21.09. | Bayer offloads cancer drug Stivarga to Grünenthal for up to $431M as new competition looms | ||
| 21.09. | The Oral GLP-1 Tracker: Holiday takes toll on prescriptions | ||
| 18.09. | Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo | ||
| 18.09. | Europe's CHMP endorses slew of new medicines, including new offerings from Novo and AstraZeneca | ||
| 18.09. | Panthers and zebras and meerkats, oh my: A peek behind the curtain at Fierce Pharma Week 2026 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.